PharmaFluidics

See how the µPAC™ capLC LC–MS column can help increase sample throughput, and at the same time maintain the highest separation efficiency and sensitivity.

See how the µPAC™ capLC LC–MS columns can contribute in the characterization of the glycosylation pattern of therapeutic enzymes.

Learn how to simplify the connectivity from your µPAC™ column to your mass spectrometer, with Nanospray Flex source. Only two connections, from column to emitter.

The µPAC™ GEN2 nanoLC columns are specifically designed to further improve your LC–MS results. More IDs and higher reproducibility for more confidence in your data.

The µPAC™ Limited Sample Amount column is designed for ultrahigh sensitive separation performance for the smallest sample amounts, typically less than 20 ng of content.

Learn about the µPAC™ trapping columns, and see how they can help sample preconcentration in nanoLC–MS. Pick your preferred workflow, forward or backflush, and run.

The unique design of the 50 cm μPAC™ GEN2 nanoLC column provides superior performance over state-of-the-art packed bed columns, achieving peak capacities of over 1000.

Simplify coupling the µPAC™ column to the emitter. Only 2 connections, an integrated liquid junction and grounding point for robust, low dispersion nanoLCMS interfacing.

***Live: Tuesday, October 13, 2020 at 9am EDT| 2pm BST| 3pm CEST*** Johannes Müller, PhD student at the Matthias Mann group in Munich, will explain how the proteome landscape of the kingdoms of life have been concluded and how the µPAC™ column was used to setup an advanced proteomic workflow that was applied in this study. *** On demand available after final airing until Oct. 13, 2021.***

PharmaFluidics’ superior fabrication robustness of microfabricated LC columns results in sub-second retention time variation over three different μPAC™ capLC columns.

PharmaFluidics’ robust microfabricated LC columns result in sub-second retention time variation over three different μPAC™ capLC columns.

PharmaFluidics introduces a new µPAC™ capLC column that offers unprecedented performance and that given its low back pressure can be used up to flow rates of 15 µL/min.

In this webcast, Dr. Jeff Op de Beeck of PharmaFluidics will explain the principles of the micro-chip based pillar array columns and demonstrate how the PharmaFluidics µPAC capLC column can contribute to LC–MS workflow robustness. Dr. Maarten Dhaenens of ProGenTomics will show high resolution DIA data of 500 ng of human proteome analyzed using either packed bed or micro-chip based pillar array columns operated at different flow rates and gradients. In his presentation, he focuses on the many different metrics that are important to proteomics analysis and the general application of LC–MS. Live:Friday, Dec. 13, 2019 at 10am EST | 9am CST | 3pm GMT | 4pm CET On demand available after airing until Dec. 13, 2020. Register free

µPAC™ technology has been used for analysing HCP impurities originating from recombinant expression systems used in the production of mAb based biotherapeutics.

μPAC™ technology has been used for analysing HCP impurities originating from recombinant expression systems used in the production of mAb based biotherapeutics.